Kinase Inhibitors in the Treatment of Ovarian Cancer: Current State and Future Promises

SIMPLE SUMMARY: Ovarian cancer is the most lethal gynecological cancer. Currently there is no curative treatment for relapsed, standard treatment resistant ovarian cancer. Here we discuss and summarize recent clinical and preclinical studies concerning the possibility to use small molecule kinase in...

Descripción completa

Detalles Bibliográficos
Autores principales: Skorda, Aikaterini, Bay, Marie Lund, Hautaniemi, Sampsa, Lahtinen, Alexandra, Kallunki, Tuula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777107/
https://www.ncbi.nlm.nih.gov/pubmed/36551745
http://dx.doi.org/10.3390/cancers14246257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777107/
https://www.ncbi.nlm.nih.gov/pubmed/36551745
http://dx.doi.org/10.3390/cancers14246257

Ejemplares similares